Literature DB >> 9918911

A model to predict survival following liver retransplantation.

H R Rosen1, J P Madden, P Martin.   

Abstract

In the current era of critical-organ shortage, one of the most controversial questions facing transplantation teams is whether hepatic retransplantation, which has historically been associated with increased resource utilization and diminished survival, should be offered to a patient whose first allograft is failing. Retransplantation effectively denies access to orthotopic liver transplantation (OLT) to another candidate and further depletes an already-limited organ supply. The study group was comprised of 1,356 adults undergoing hepatic retransplantation in the United States between 1990 and 1996 as reported to the United Network for Organ Sharing (UNOS). We analyzed numerous donor and recipient variables and created Cox proportional-hazards models on 900 randomly chosen patients, validating the results on the remaining cohort. Five variables consistently provided significant predictive power and made up the final model: age, bilirubin, creatinine, UNOS status, and cause of graft failure. Although both hepatitis C seropositivity and donor age were significant by univariate and multivariate analyses, neither contributed independently to the estimation of prognosis when added to the final model. The final model was highly predictive of survival (whole model chi2 = 139.63). The risk scores for individual patients were calculated, and patients were assigned into low-, medium-, and high-risk groups (P <.00001). The low degree of uncertainty in the probability estimates as reflected by confidence intervals, even in our high-risk patients, underscores the applicability of our model as an adjunct to clinical judgment. We have developed and validated a model that uses five readily accessible "bedside" variables to accurately predict survival in patients undergoing liver retransplantation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918911     DOI: 10.1002/hep.510290221

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  20 in total

Review 1.  Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.

Authors:  Kymberly D S Watt; Kelly Burak; Marc Deschênes; Les Lilly; Denis Marleau; Paul Marotta; Andrew Mason; Kevork M Peltekian; Eberhard L Renner; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2006-11       Impact factor: 3.522

2.  Hepatitis C viral infection after liver transplantation.

Authors:  Elizabeth C Verna; Robert S Brown
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-07-23

3.  The elderly liver transplant recipient: a call for caution.

Authors:  M F Levy; P S Somasundar; L W Jennings; G J Jung; E P Molmenti; C G Fasola; R M Goldstein; T A Gonwa; G B Klintmalm
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

4.  Decision for retransplantation of the liver: an experience- and cost-based analysis.

Authors:  Daniel Azoulay; Marcello M Linhares; Emmanuel Huguet; Valérie Delvart; Denis Castaing; René Adam; Philippe Ichai; Faouzi Saliba; Antoinette Lemoine; Didier Samuel; Henri Bismuth
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

Review 5.  Management of recurrent hepatitis C virus after liver transplantation.

Authors:  Miguel Jiménez-Pérez; Rocío González-Grande; Francisco Javier Rando-Muñoz
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

6.  Short- and long-term outcomes of third liver transplantation at single centre.

Authors:  Hideya Kamei; Mamoun Al-Basheer; Jeffrey Shum; Michael Bloch; Roberto Hernandez Alejandro; Vivian McAlister; William Wall; Douglas Quan
Journal:  Hepatol Int       Date:  2012-03-14       Impact factor: 6.047

7.  Significant influence of the primary liver disease on the outcomes of hepatic retransplantation.

Authors:  A Qasim; B M Zaman; J Geoghegan; D Maguire; O Traynor; J Hegarty; P A McCormick
Journal:  Ir J Med Sci       Date:  2008-11-04       Impact factor: 1.568

8.  Effects of graft quality on non-urgent liver retransplantation survival: should we avoid high-risk donors?

Authors:  Josep Marti; Josep Fuster; Miquel Navasa; Joana Ferrer; Antoni Rimola; Amalia Pelegrina; Constantino Fondevila; Juan Carlos Garcia-Valdecasas
Journal:  World J Surg       Date:  2012-12       Impact factor: 3.352

9.  Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.

Authors:  Alice Tung Wan Song; Rodolphe Sobesky; Carmen Vinaixa; Jérôme Dumortier; Sylvie Radenne; François Durand; Yvon Calmus; Géraldine Rousseau; Marianne Latournerie; Cyrille Feray; Valérie Delvart; Bruno Roche; Stéphanie Haim-Boukobza; Anne-Marie Roque-Afonso; Denis Castaing; Edson Abdala; Luiz Augusto Carneiro D'Albuquerque; Jean-Charles Duclos-Vallée; Marina Berenguer; Didier Samuel
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

10.  Pretransplant model to predict posttransplant survival in liver transplant patients.

Authors:  Rafik M Ghobrial; Jeffery Gornbein; Randy Steadman; Natale Danino; James F Markmann; Curtis Holt; Dean Anselmo; Farin Amersi; Pauline Chen; Douglas G Farmer; Steve Han; Francisco Derazo; Sammy Saab; Leonard I Goldstein; Sue V McDiarmid; Ronald W Busuttil
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.